Great differences were found in tumor behavior, clinical manifestation, treatment response, and prognosis among different breast cancer types.6 Targeted therapy has become encouraging in breast cancer treatment, when estrogen receptor (ER) status was demonstrated to be an important treatment and prognostic factor in the last 10 years. This evidence concerns the gene ESR1 and breast carcinoma.